Below you will find information from the register publication of inside information. The information has been provided by the organisation.
- Registration date 26 mrt 2018 - 08:18
- Statutory name argenx SE
- Title argenx announces orphan drug designation for ARGX-113 for the treatment of myasthenia gravis in Europe
|201803260000000004_argenx announces orphan drug designation for ARGX.docx|
Date last update: 19 January 2019